Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2010-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-09-0486PMID 20053773PMCID PMC2806502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylation of Stat1 promoter can contribute to squamous cell carcinogenesis.

  2006cited by this paper
• Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma

  2006cited by this paper
• Epigenetic regulation of MHC-II and CIITA genes.

  2006influential reference
• Molecular Cancer Methylation Mediated Silencing of Tms1/asc Gene in Prostate Cancer

  2006cited by this paper
• Trends in the leading causes of death in the United States, 1970-2002.

  2005cited by this paper
• Survey of differentially methylated promoters in prostate cancer cell lines.

  2005cited by this paper
• Multigene Methylation Analysis for Detection and Staging of Prostate Cancer

  2005cited by this paper
• A Quantitative Promoter Methylation Profile of Prostate Cancer

  2004cited by this paper
• Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer

  2004cited by this paper
• Identification of differentially methylated CpG islands in prostate cancer

  2004cited by this paper
• High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.

  2004cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Altered methylation of multiple genes in carcinogenesis of the prostate

  2003cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

  2002cited by this paper
• Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas.

  2002cited by this paper
• Emerging molecular markers of cancer

  2002cited by this paper
• Methylation and mutational analysis of p27kip1 in prostate carcinoma

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001influential reference
• TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.

  2000cited by this paper
• Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

  2000cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Prognostic factors for clinically localized prostate carcinoma

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues.

  1980cited by this paper

• Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf

  2025cites this paper
• ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer.

  2025cites this paper
• Coordinated Transcriptomic and Epigenetic Approach Reveals Molecular Features Underlying Natural Mating Ability in Captive Male Giant Pandas

  2025cites this paper
• DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications

  2025cites this paper
• Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data

  2025cites this paper
• Epigenetic regulation of androgen dependent and independent prostate cancer.

  2024cites this paper
• Black carp RIOK3 suppresses MDA5-mediated IFN signaling in the antiviral innate immunity.

  2023cites this paper
• G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.

  2022cites this paper
• Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer

  2022cites this paper
• Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.

  2021cites this paper
• ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance

  2020cites this paper
• Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of MGMT, TRA2A, RPS6KA2, and U2AF1 Genes in Prostate Cancer Cell Lines

  2020cites this paper
• Prostate Carcinogenesis: Insights in relation to Epigenetics and Inflammation.

  2020cites this paper
• Epigenetic regulation of enhancer regions in breast cancer cells in response to pterostilbene

  2020cites this paper
• Regulation of the Antioxidant Response by MyoD Transcriptional Coactivator in Castration-resistant Prostate Cancer Cells.

  2019cites this paper
• Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells

  2018cites this paper
• Genome-Wide Methylation Patterns in Androgen-Independent Prostate Cancer Cells: A Comprehensive Analysis Combining MeDIP-Bisulfite, RNA, and microRNA Sequencing Data

  2018cites this paper
• Optimization Of Cancer Treatment Through Overcoming Drug Resistance

  2018cites this paper
• A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2

  2018cites this paper
• Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.

  2017cites this paper
• Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet's disease

  2017cites this paper
• Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers.

  2016cites this paper
• Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort

  2016cites this paper
• Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy

  2016cites this paper
• Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells.

  2016cites this paper
• Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis.

  2016cites this paper
• Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile.

  2016cites this paper
• Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection

  2016cites this paper
• Distal regulatory element of the STAT1 gene potentially mediates positive feedback control of STAT1 expression

  2016cites this paper
• Epigenetics in breast and prostate cancer.

  2015cites this paper
• Changes of protein expression in prostate cancer having lost its androgen sensitivity

  2015cites this paper
• Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells

  2015cites this paper
• Frequent down-regulation of ABC transporter genes in prostate cancer

  2015cites this paper
• Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design

  2015cites this paper
• DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer

  2015cites this paper
• The Core Promoter and Redox-sensitive Cis-elements as Key Targets for Inactivation of the Lysyl Oxidase Gene by Cadmium.

  2015cites this paper
• Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects.

  2015cites this paper
• Prostate cancer: The main risk and protective factors-Epigenetic modifications.

  2015cites this paper
• Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo

  2015cites this paper
• Down‐regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia

  2015cites this paper
• Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer

  2015cites this paper
• Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.

  2015cites this paper
• DNAMethylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer

  2015cites this paper
• The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.

  2015cites this paper
• Identification of novel tumor predisposition families and underlying genetic defects

  2014cites this paper
• Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma

  2014cites this paper
• Analysis of Candidate Genes Has Proposed the Role of Y Chromosome in Human Prostate Cancer

  2014cites this paper
• NNK, a Tobacco-Specific Carcinogen, Inhibits the Expression of Lysyl Oxidase, a Tumor Suppressor

  2014cites this paper
• Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.

  2014cites this paper
• Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.

  2014cites this paper
• A comparison of the gene expression profiles and pathway network analyses after treatment of Prostate cancer cell lines with different Ganoderma lucidum based extracts.

  2014cites this paper
• Fragile Histidine Triad (FHIT) Suppresses Proliferation and Promotes Apoptosis in Cholangiocarcinoma Cells by Blocking PI3K-Akt Pathway

  2014cites this paper
• Androgen Receptor Function Links Human Sexual Dimorphism to DNA Methylation

  2013cites this paper
• Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspase-independent cell death.

  2013cites this paper
• In vitro model systems to study androgen receptor signaling in prostate cancer.

  2013cites this paper
• Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies.

  2013cites this paper
• CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

  2013cites this paper
• MyoD is a tumor suppressor gene in medulloblastoma.

  2013cites this paper
• Genetic Basis of Familial Lymphoma Predisposition

  2013cites this paper
• Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.

  2013cites this paper
• Genistein and daidzein: different molecular effects on prostate cancer.

  2013cites this paper
• Global DNA methylation screening of liver in piperonyl butoxide-treated mice in a two-stage hepatocarcinogenesis model.

  2013cites this paper
• Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

  2012cites this paper
• Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis*

  2012cites this paper
• STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

  2012cites this paper
• Understanding the role of the Sonic Hedgehog signaling pathway in cerebellar development and medulloblastoma genesis

  2012cites this paper
• Molecular Genetic and DNA Methylation Profiling of Chronic Lymphocytic Leukaemia : A Focus on Divergent Prognostic Subgroups and Subsets

  2012cites this paper
• Macrocylic bisbibenzyl natural products and their chemical synthesis.

  2012cites this paper
• Biological Effects of Soy Isoflavones

  2012cites this paper
• Cell - to Species-Level Diversity of Epigenetic Setting for Androgen Receptor Expression in Mammals

  2012cites this paper
• TGF-β mediated DNA methylation in prostate cancer

  2012cites this paper
• DNA methylation in promoter region as biomarkers in prostate cancer.

  2012cites this paper
• DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human

  2011cites this paper
• Selenoprotein‐P is down‐regulated in prostate cancer, which results in lack of protection against oxidative damage

  2011cites this paper
• Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells

  2011cites this paper
• Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.

  2011cites this paper
• Hypomethylating agents for urologic cancers.

  2011cites this paper
• Defining Phenotypes and Cancer Risk in Hyperplastic Polyposis Syndrome

  2011cites this paper
• DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.

  2011cites this paper
• Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.

  2011cites this paper
• Pax6 Represses Androgen Receptor-Mediated Transactivation by Inhibiting Recruitment of the Coactivator SPBP

  2011cites this paper
• Pax6 localizes to chromatin-rich territories and displays a slow nuclear mobility altered by disease mutations

  2010cites this paper
• Oxidative Stress and DNA Methylation in Prostate Cancer

  2010cites this paper
• Gene expression correlation analysis predicts involvement of high‐ and low‐confidence risk genes in different stages of prostate carcinogenesis

  2010cites this paper
• [Pyrosequencing in uro-oncology: applications in prostate cancer].

  2010cites this paper